Cardiovascular System: Blood (copy)

Primary Functions and Composition of Blood

• Blood as Connective Tissue

  • Blood is classified as a fluid connective tissue composed of cellular elements suspended in a liquid extracellular matrix (ECM).
  • Cellular Elements (Formed Elements):
    • Erythrocytes (Red Blood Cells / RBCs).
    • Leukocytes (White Blood Cells / WBCs).
    • Thrombocytes (Platelets).
  • Extracellular Matrix (ECM):
    • Plasma, which is predominantly water ($92\%$).

• Primary Functions of Blood

  • Transportation:
    • Nutrients: Ingested food nutrients are absorbed in the gastrointestinal (GI) tract, transported via the bloodstream primarily to the liver for processing, and subsequently distributed to target body cells.
    • Oxygen and Carbon Dioxide: Oxygen diffuses into blood within the pulmonary capillaries of the lungs, returns to the heart, and is pumped throughout systemic circulation. Carbon dioxide is collected from metabolic tissues and transported back to the lungs for exhalation.
    • Hormones: Endocrine glands secrete hormones directly into blood plasma for transport to target organ receptors.
    • Metabolic Wastes: Cellular waste products are carried through the blood to excretory organs, such as the liver and kidneys, for neutralization and elimination.
  • Defense Mechanisms:
    • External and Pathogenic Threats: Leukocytes defend against external pathogens entering through compromised tissue (e.g., bacteria in a wound) and internal threats (e.g., cells with mutated DNA or intracellular viral infections).
    • Vascular Integrity: Platelets and plasma proteins mediate coagulation to prevent excessive hemorrhage following vascular trauma.
  • Homeostatic Regulation:
    • Thermoregulation: Absorbs and redistributes heat throughout the body.
    • Chemical Balance: Maintains systemic pH equilibrium and optimal intracellular/extracellular fluid volume.

• Physical Characteristics of Blood

  • Color: Hemoglobin pigment varies in shade based on oxygenation state. High oxygen content yields bright red blood; oxygen-depleted blood displays a dusky red appearance.
  • Viscosity: Blood is approximately $5\times$ more viscous than water. Viscosity directly influences vascular resistance, blood pressure, and blood flow velocity.
  • Temperature: Normal blood temperature is slightly higher than internal core body temperature, measuring approximately $100.4\,^\circ\text{F}$ ($38\,^\circ\text{C}$).
  • pH: Slightly alkaline, maintained strictly between $7.35$ and $7.45$
  • Volume: Accounts for approximately $8\%$ of total adult body weight.
    • Adult Males: $5 - 6\,\text{L}$.
    • Adult Females: $4 - 5\,\text{L}$.

Blood Fractionation, Plasma Components, and Diagnostic Ranges

• Centrifugation and Centrifuged Components

  • Centrifugation separates whole blood into distinct fractions based on density:
    • Hematocrit (Packed Cell Volume / PCV): The percentage of total blood volume occupied by dense, erythrocytes that settle at the bottom of the tube. Normal baseline PCV averages approximately $45\%$ (Standard ranges: Females $37\% - 47\%$, Males $42\% - 52\%$).
    • Buffy Coat: A thin intermediate layer located directly above the erythrocyte fraction. Contains leukocytes and platelets, representing $<1\%$ of total blood volume.
    • Plasma: The superficial liquid layer occupying $46\% - 63\%$ (typically $\approx 55\%$) of total blood volume.
  • Hematocrit Deviations:
    • Anemia: Depressed hematocrit percentage below normal standard thresholds.
    • Polycythemia: Abnormally elevated hematocrit percentage.

• Detailed Blood Plasma Composition

  • Water Component: Comprises $92\%$ of total plasma volume; functions as a transport medium.
  • Plasma Proteins ($7\%$ of total plasma volume):
    • Albumin: Synthesized by the liver; accounts for $54\% - 60\%$ of all plasma proteins. Functions as a transport/binding protein for fatty acids and steroid hormones. Primary contributor to colloid osmotic pressure (oncotic pressure) of blood.
    • Globulins: Accounts for $35\% - 38\%$ of plasma proteins.
      • Alpha ($\alpha$) and Beta ($\beta$) Globulins: Synthesized in the liver; transport iron, lipids, and fat-soluble vitamins ($\text{A}$, $\text{D}$, $\text{E}$, $\text{K}$) while maintaining osmotic concentration.
      • Gamma ($\gamma$) Globulins (Immunoglobulins / Antibodies): Produced by antigen-stimulated plasma cells (differentiated B lymphocytes); mediate specific humoral immune responses.
    • Fibrinogen: Synthesized by the liver; accounts for $4\% - 7\%$ of plasma proteins. Insoluble fibrin precursor essential for blood clotting and hemostasis.
    • Regulatory Proteins: Comprise $<1\%$ of plasma proteins; include peptide hormones, enzymes, and proenzymes from varied systemic sources.
  • Other Plasma Solutes ($1\%$ of total plasma volume):
    • Electrolytes: Inorganic ions including sodium ($\text{Na}^+$), potassium ($\text{K}^+$), and calcium ($\text{Ca}^{2+}$).
    • Dissolved Gases: Oxygen ($\text{O}_2$), carbon dioxide ($\text{CO}_2$), and nitrogen ($\text{N}_2$).
    • Organic Nutrients & Wastes: Glucose, amino acids, lipids, vitamins, and nitrogenous metabolic waste products (urea, uric acid, creatinine).

• Standard Complete Blood Count (CBC) and Differential Reference Ranges

  • White Blood Cell Count (WBC): Standard Range $4.0 - 11.0\,\text{K}/\mu\text{L}$.
  • Red Blood Cell Count (RBC): Standard Range $4.40 - 6.00\,\text{M}/\mu\text{L}$.
  • Hemoglobin (Hgb): Standard Range $13.5 - 18.0\,\text{g/dL}$.
  • Hematocrit (Hct): Standard Range $40.0\% - 52.0\%$.
  • Mean Corpuscular Volume (MCV): Standard Range $80 - 100\,\text{fL}$.
  • Mean Corpuscular Hemoglobin (MCH): Standard Range $27.0 - 33.0\,\text{pg}$.
  • Mean Corpuscular Hemoglobin Concentration (MCHC): Standard Range $31.0 - 36.0\,\text{g/dL}$.
  • Red Cell Distribution Width (RDW): Standard Range $<16.4\%$.
  • Platelet Count: Standard Range $150 - 400\,\text{K}/\mu\text{L}$.
  • Differential Counts (Automated):
    • Neutrophil %: Standard Range $49.0\% - 74.0\%$ | Absolute: $2.0 - 8.0\,\text{K}/\mu\text{L}$.
    • Lymphocyte %: Standard Range $26.0\% - 46.0\%$ | Absolute: $1.0 - 5.1\,\text{K}/\mu\text{L}$.
    • Monocyte %: Standard Range $2.0\% - 12.0\%$ | Absolute: $0.0 - 0.8\,\text{K}/\mu\text{L}$.
    • Eosinophil %: Standard Range $0.0\% - 5.0\%$ | Absolute: $0.0 - 0.5\,\text{K}/\mu\text{L}$.
    • Basophil %: Standard Range $0.0\% - 2.0\%$ | Absolute: $0.0 - 0.2\,\text{K}/\mu\text{L}$.

Hemopoiesis and Stem Cell Differentiation

• Lifespan and Turnover Rates of Formed Elements

  • Formed element lifespans range from hours to weeks, with specific exceptions:
    • Erythrocytes average a lifespan of $120\text{ days}$.
    • Memory B and T lymphocytes survive for multiple years.
  • Donated blood plasma volume is naturally replenished within $24\text{ hours}$.
  • Full cellular replacement via hemopoiesis requires $4 - 6\text{ weeks}$, governing standard whole blood donation interval requirements ($8\text{ weeks}$ between donations; plasma-only donations permitted up to $2\times/\text{week}$).

• Anatomical Sites of Hematopoiesis Across Lifespan

  • Prenatal Development: Begins initially in the embryonic yolk sac, later shifting to the fetal liver, spleen, lymphatic tissue, and developing red bone marrow.
  • Postnatal & Pediatric Stage: Occurs universally within the red bone marrow, including the medullary cavities of long bones.
  • Adult Stage: Restricted to the axial skeleton and select proximal appendicular sites: cranial bones, pelvic bones (iliac crest), vertebrae, sternum, and the proximal epiphyses of the femur and humerus.
  • Extramedullary Hematopoiesis: Pathological or compensatory generation of formed elements outside bone marrow, occurring within the adult liver and spleen.

• Stem Cell Potency and Differentiation Pathways

  • All formed elements originate from multipotent hematopoietic stem cells (hemocytoblasts) residing in red bone marrow.
  • Stem Cell Potency Hierarchy:
    • Totipotent Stem Cell: Zygote/fertilized egg; capable of giving rise to all cell types of the human body including extraembryonic tissues.
    • Pluripotent Stem Cell: Gives rise to multiple distinct germ layer cell lines.
    • Mesenchymal Stem Cell: Differentiates exclusively into connective tissue subtypes.
    • Multipotent Hematopoietic Stem Cell (Hemocytoblast): Differentiates strictly into all formed elements of blood.
  • Cell Division Mechanisms:
    • Symmetric cell division produces identical daughter stem cells.
    • Asymmetric cell division yields one self-renewing stem cell and one differentiating daughter cell conditioned by cytoplasmic fate determinants and chemical factors.
  • Primary Differentiation Lineages:
    • Lymphoid Stem Cells: Give rise to lymphoblasts, which differentiate into:
      • Natural Killer (NK) cells (large granular lymphocytes).
      • Small lymphocytes: T lymphocytes (mature in thymus) and B lymphocytes (mature in bone marrow).
    • Myeloid Stem Cells: Give rise to all non-lymphoid formed elements:
      • Proerythroblasts $\rightarrow$ Reticulocytes $\rightarrow$ Mature Erythrocytes.
      • Megakaryoblasts $\rightarrow$ Megakaryocytes $\rightarrow$ Platelet cytoplasmic fragments.
      • Myeloblasts $\rightarrow$ Granular Leukocytes (Neutrophils, Eosinophils, Basophils).
      • Monoblasts $\rightarrow$ Monocytes.

• Hemopoietic Growth Factors

  • Erythropoietin (EPO): Glycoprotein hormone secreted by interstitial renal fibroblasts of the kidneys in response to tissue hypoxia. Stimulates proerythroblasts to accelerate erythrocyte maturation and release. Exogenous EPO is utilized illicitly in athletic blood doping to augment aerobic performance.
  • Thrombopoietin: Glycoprotein synthesized continuously by the liver and kidneys. Stimulates megakaryocyte development and maturation into functional platelets.
  • Cytokines: Glycoproteins secreted by red bone marrow stromal cells, leukocytes, macrophages, endothelial cells, and fibroblasts.
    • Colony-Stimulating Factors (CSFs): Paracrine or autocrine signals driving myeloblast differentiation into specific leukocyte strains and monocyte production.
    • Interleukins: Signaling molecules produced by endothelial cells and bone marrow cells that coordinate hemopoiesis, inflammation, and adaptive immunity.

• Clinical Bone Marrow Procedures

  • Bone Marrow Biopsy: Extraction of bone marrow tissue using a large-bore needle (typically from the posterior iliac crest) to diagnose and stage hematologic malignancies (e.g., leukemias, lymphomas).
  • Bone Marrow / Hematopoietic Stem Cell Transplant: Replacement of defective or aplastic marrow with healthy donor stem cells.
  • Modern Peripheral Blood Stem Cell Harvesting: Stem cells are mobilized into the donor's peripheral blood, isolated via apheresis, incubated with targeted antibodies for selection, volume-reduced, cryopreserved, and subsequently thawed for intravenous infusion following patient conditioning via chemotherapy or radiation therapy.

Erythrocyte Structure, Function, and Lifecycle

• Structural Characteristics of Erythrocytes

  • Erythrocytes are the most abundant formed element, comprising $\approx 25\%$ of all cells in the human body. Count ranges from $4.40 - 6.00\,\text{M}/\mu\text{L}$.
  • Dimensions: Small diameter measuring $7 - 8\,\mu\text{m}$.
  • Anatomical Adaptation: Mature erythrocytes extrude their nucleus and cellular organelles prior to peripheral circulation release.
  • Reticulocytes: Immature erythrocytes containing residual ribosomal RNA, representing $1\% - 2\%$ of total circulating RBC count.
  • Metabolic Profile: Lack mitochondria; rely entirely on anaerobic glycolysis for ATP production, preventing consumption of the oxygen they transport.
  • Biconcave Disc Morphology: High surface area-to-volume ratio optimizes gas diffusion rates. Flexible structural proteins permit erythrocytes to bend, fold, and stack (rouleaux) to negotiate microvasculature capillaries with diameters smaller than $7\,\mu\text{m}$, slowing flow to maximize gas exchange time.

• Hemoglobin Structure and Gas Transport

  • Molecular Architecture: Composed of four globin polypeptide chains ($2\,\alpha$ chains and $2\,\beta$ chains).
  • Heme Complex: Each globin subunit is bound to an iron-containing heme molecule ($\text{Fe}^{2+}$).
  • Binding Capacity: Each central iron atom reversibly binds one molecule of oxygen ($\text{O}_2$). Each single hemoglobin molecule transports up to $4\,\text{O}_2$ molecules. Single erythrocytes contain $\approx 300\,\text{million}$ hemoglobin molecules, allowing transport of up to $1.2\,\text{billion}$ oxygen molecules per RBC.
  • Chemical States:
    • Oxyhemoglobin: Heme bound to oxygen; exhibits a bright red color.
    • Deoxyhemoglobin: Heme stripped of oxygen; exhibits a dark dusky red color.
    • Carbaminohemoglobin: Carbon dioxide bound directly to amino acid residues on the globin chains (accounts for $\approx 23\% - 24\%$ of total systemic $\text{CO}_2$ transport; $\approx 76\%$ of $\text{CO}_2$ dissolves in plasma or converts to bicarbonate ions $\text{HCO}_3^-$).

• Renal Regulation of Erythropoiesis

  • Oxygen-sensing receptors in renal tissue detect vascular arterial oxygen saturation levels.
  • Hypoxia in renal tissue induces interstitial fibroblasts to secrete EPO into the blood.
  • EPO travels to red bone marrow, stimulating proerythroblast proliferation and reticulocyte release.
  • Elevated systemic oxygenation provides negative feedback, dampening renal EPO secretion.
  • High Altitude Adaptation: Atmospheric hypoxia triggers renal EPO secretion, increasing hematocrit to preserve tissue oxygen delivery. Unadapted individuals ascending rapidly may experience acute altitude sickness (fatigue, headache, shortness of breath) requiring acclimatization or supplemental oxygen.

• Nutritional Requirements for Erythropoiesis

  • Macronutrients: Adequate dietary glucose, lipids, and amino acids.
  • Trace Minerals:
    • Iron: Essential for heme synthesis. Ingested as heme iron (animal source, higher bioavailability) or non-heme iron (plant source). Less than $20\%$ of dietary iron is absorbed. Stored intracellularly as ferritin and hemosiderin in the liver, spleen, and bone marrow. Transported across intestinal membrane by ferroportin and carried in plasma bound to transferrin.
    • Copper: Component of plasma proteins ceruloplasmin and hephaestin. Hephaestin in intestinal villi enables iron oxidation ($\text{Fe}^{2+} \rightarrow \text{Fe}^{3+}$) necessary for transferrin binding. Ceruloplasmin transports copper. Copper deficiency causes tissue iron accumulation.
    • Zinc: Serves as an enzymatic co-factor in the biosynthetic pathway of heme synthesis.
  • B-Vitamins: Vitamin $\text{B}_{12}$ (cobalamin) and Folate (Vitamin $\text{B}_9$) act as essential co-enzymes required for DNA synthesis during rapid erythroblast mitotic division.

• Erythrocyte Degradation and Recycling

  • Old or damaged RBCs ($>120\text{ days}$) are phagocytized by tissue macrophages in the spleen, liver, and bone marrow.
  • Globin Processing: Hydroolyzed into free amino acids, which are released into blood for cellular protein synthesis. Free hemoglobin escaping phagocytosis is filtered and cleared by kidneys.
  • Iron Recycling: Iron is stripped from heme, stored as ferritin or hemosiderin in the liver/spleen, or exported bound to transferrin for recycling in bone marrow hemopoiesis.
  • Non-Iron Heme Processing:
    • Degraded into biliverdin (green pigment).
    • Reduced to bilirubin (yellow pigment), which binds to plasma albumin and travels to the liver.
    • Liver excretes bilirubin into bile to emulsify dietary fats in the duodenum.
    • Intestinal bacteria convert bilirubin to urobilinogen and stercobilin (giving feces its brown color).
    • Urobilinogen excreted by the kidneys imparts a yellow color to urine.

Erythrocyte and Hemoglobin Disorders

• Erythrocyte Pathologies: Anemia

  • Anemia is defined as a deficiency in RBC count, hematocrit, or functional hemoglobin content leading to tissue hypoxia. Symptoms include fatigue, shortness of breath (SOB), headaches, irritability, and dizziness.
  • Anemia Caused by Acute or Chronic Blood Loss:
    • Gastrointestinal bleeding (peptic ulcers, gastritis, hemorrhoids, GI malignancies).
    • Menorrhagia (excessive menstrual bleeding due to uterine fibroids, endometriosis, or endocrine dysfunction).
  • Anemia Caused by Faulty or Decreased RBC Production:
    • Sickle Cell Disease: Autosomal recessive genetic disorder causing single amino acid mutation in $\beta$-globin chain. Promotes hemoglobin polymerization under low oxygen tension, forming rigid, crescent-shaped ("sickle") RBCs that cause vaso-occlusion, ischemia, and hemolysis. Common in individuals of African descent. Heterozygotes are carriers (sickle cell trait).
    • Iron-Deficiency Anemia: Microcytic, hypochromic anemia resulting from inadequate iron intake, impaired absorption, or chronic blood loss. Elevated prevalence in vegan/vegetarian populations.
    • Pernicious Anemia: Autoimmune destruction of gastric parietal cells, preventing intrinsic factor secretion required for ileal Vitamin $\text{B}_{12}$ absorption, resulting in macrocytic anemia.
    • Malabsorption Disorders: Crohn's disease, celiac disease, or pharmacological inhibition (proton pump inhibitors, metformin).
    • Aplastic Anemia: Bone marrow failure resulting in pancytopenia, caused by inherited conditions, toxins, or radiation.
    • Thalassemias: Inherited quantitative defects in globin chain synthesis ($\alpha$- or $\beta$-thalassemia; minor or major variants).
    • Toxicities & Chronic Disease: Lead exposure destroys red bone marrow; Chronic Kidney Disease (CKD) impairs EPO production; hypothyroidism, lupus, and rheumatoid arthritis impair erythropoiesis.
  • Anemia Caused by Erythrocyte Destruction (Hemolytic Anemia): Autoimmune destruction, G6PD deficiency, or structural hemoglobinopathies.

• Erythrocyte Pathologies: Polycythemia

  • Characterized by an abnormally elevated hematocrit and increased blood viscosity.
  • Transient Polycythemia: Secondary to dehydration or exogenous testosterone replacement therapy.
  • Physiological Polycythemia: Secondary to chronic hypoxic adaptation (high altitude living).
  • Polycythemia Vera: Primary bone marrow neoplasm characterized by unregulated, autonomous production of immature erythrocytes.

Leukocytes: Characteristics, Classification, and Functions

• General Characteristics and Diapedesis

  • Leukocytes are nucleated cells containing complete organelles; present in significantly smaller numbers than erythrocytes ($4.0 - 11.0\,\text{K}/\mu\text{L}$).
  • Retain mitotic capability to form clones for immunological memory.
  • Emigration (Diapedesis): Process by which leukocytes squeeze between adjacent endothelial cells lining capillaries to enter extravascular tissues.
  • Positive Chemotaxis: Directional movement toward target tissues in response to chemical attractants (chemokines, kinins, pathogen markers) released by damaged host cells or invasive pathogens.

• Granulocytes (Granular Leukocytes)

  • Contain prominent cytoplasmic granules; originate from myeloid stem cells.
  • Neutrophils:
    • Prevalence: Most abundant, constituting $50\% - 70\%$ of total circulating WBCs.
    • Morphology: Multi-lobed nucleus ($3 - 5$ lobes connected by thin strands). Mature forms termed polymorphonuclear leukocytes (PMNs); immature forms termed bands.
    • Function: Rapid first responders to acute bacterial infections. Granules contain lysozyme, defensins, and strong oxidizing agents (e.g., hydrogen peroxide $\text{H}_2\text{O}_2$).
  • Eosinophils:
    • Prevalence: Constitute $2\% - 4\%$ of total WBCs.
    • Morphology: Typically $2 - 3$ lobed nucleus; large granules that stain bright red/orange with acidic dyes.
    • Function: Counteract histamine in allergic responses; secrete cytotoxic proteins toxic to parasitic helminths/worms; perform immune complex phagocytosis.
  • Basophils:
    • Prevalence: Rarest leukocyte, constituting $<1\%$ of total WBCs.
    • Morphology: Two-lobed obscured nucleus; coarse granules that stain dark blue/purple with basic dyes.
    • Function: Promotes acute inflammatory responses. Granules contain histamine (vasodilator) and heparin (anticoagulant). Associated with systemic hypersensitivity reactions, parasitic infections, and hypothyroidism.

• Agranulocytes (Agranular Leukocytes)

  • Lack prominent microscopic cytoplasmic granules; possess simple, unlobed nuclei.
  • Lymphocytes:
    • Prevalence: Constitute $20\% - 30\%$ of total WBCs.
    • Morphology: Large dark-staining nucleus occupying most of the cellular volume with a thin rim of pale blue cytoplasm. Derived from lymphoid stem cells.
    • Subtypes:
      • Natural Killer (NK) Cells: Mediate innate nonspecific immunity. Recognize and lyse host cells lacking surface self-MHC class I proteins or bearing abnormal viral/tumor markers.
      • B Lymphocytes (B Cells): Mediate specific humoral immunity. Mature in bone marrow. Differentiate into antibody-secreting plasma cells.
      • T Lymphocytes (T Cells): Mediate specific cellular immunity. Mature in the thymus. Directly attack infected, foreign, or mutated cells.
      • Memory Cells: Subpopulations of B and T cells that persist for years to execute accelerated secondary immune responses.
  • Monocytes:
    • Prevalence: Constitute $2\% - 8\%$ of total WBCs.
    • Morphology: Abundantly large cells with characteristic indentation/horseshoe-shaped nucleus. Derived from myeloid stem cells.
    • Function: Emigrate from systemic blood into tissue space to transform into Macrophages. Phagocytize cellular debris, pathogens, and apoptotic cells. Release antimicrobial defensins and chemotactic factors to recruit other leukocytes.

• Clinical Etiologies of Leukocyte Differential Shifts

  • Neutrophils: High levels indicate bacterial infection, fungal infection, or burn trauma. Low levels indicate chemotherapy drug toxicity or aplastic bone marrow disorders.
  • Eosinophils: High levels indicate allergic reactions, parasitic infection, or autoimmune disorders. Low levels indicate steroid toxicity or acute stress.
  • Basophils: High levels indicate allergies, parasites, or hypothyroidism. Low levels indicate pregnancy, acute stress, or hyperthyroidism.
  • Lymphocytes: High levels indicate acute viral infections or lymphoid leukemias. Low levels indicate chronic illness, advanced HIV infection, or immunosuppressive therapy.
  • Monocytes: High levels indicate chronic viral/fungal infections, tuberculosis, or leukemia. Low levels indicate bone marrow suppression.

• Leukocyte Disorders

  • Leukopenia: Pathologically low leukocyte count ($<4.0\,\text{K}/\mu\text{L}$), exposing the host to opportunistic infections.
  • Leukocytosis: Elevated leukocyte count ($>11.0\,\text{K}/\mu\text{L}$); can be protective or secondary to non-functional neoplastic proliferation.
  • Leukemia: Hematologic malignancy characterized by overproduction of abnormal, non-functional leukocytes.
    • Myelocytic Leukemia: Neoplastic transformation along the myeloid cell lineage.
    • Lymphoid Leukemia: Neoplastic transformation along the lymphoid cell lineage.
    • Chronic Leukemia: Accumulation of mature leukocytes that fail to undergo apoptosis.
    • Acute Leukemia: Uncontrolled blast cell proliferation of immature, non-functional leukocytes.
  • Lymphoma: Malignant proliferation of T and B lymphocytes that aggregate within lymph nodes, spleen, liver, and lymphoid tissues. Can present as indolent (slow-growing) or aggressive variants.

Platelet Structure and the Process of Hemostasis

• Platelet Structure and Pathologies

  • Platelets (Thrombocytes) are non-cellular cytoplasmic fragments shed from polyploid megakaryocytes in red bone marrow. Count ranges from $150 - 400\,\text{K}/\mu\text{L}$. Lifespan is approximately $10\text{ days}$.
  • Thrombocytosis: Abnormally high platelet count ($>400\,\text{K}/\mu\text{L}$ or $>450\,\text{K}/\mu\text{L}), predisposing patients to spontaneous thrombosis.\n * **Thrombocytopenia:** Abnormally low platelet count (<150\,\text{K}/\mu\text{L} or $

• The Three Stages of Hemostasis

  • Hemostasis represents the rapid physiological sequence designed to stop vascular hemorrhage following endothelial disruption.
  • Stage 1: Vascular Spasm:
    • Duration: Lasts approximately $30\text{ minutes}$.
    • Mechanism: Vascular smooth muscle in the injured vessel wall contracts, inducing localized vasoconstriction to diminish blood flow.
    • Triggers: Paracrine paracontractile chemical endothelins secreted by damaged endothelial cells, nociceptor pain reflexes, and direct vascular smooth muscle trauma.
  • Stage 2: Formation of Platelet Plug:
    • Timeline: Commences within $15 - 20\text{ seconds}$; completes within $\approx 1\text{ minute}$.
    • Mechanism: Endothelial damage exposes underlying subendothelial collagen fibers. Circulating von Willebrand factor (vWF) binds collagen and acts as cellular glue, facilitating platelet adhesion.
    • Platelet Activation: Adherent platelets change morphology (develop spiked pseudopods) and degranulate, releasing active chemical mediators:
      • Adenosine Diphosphate (ADP): Recruits and promotes adhesion of additional platelets.
      • Serotonin: Sustains vascular smooth muscle contraction (vasoconstriction).
      • Prostaglandins and Phospholipids: Maintain vasoconstriction and activate local enzymatic clotting cascades.
    • Forms a temporary physical barrier while definitive repair occurs.
  • Stage 3: Coagulation (Clot Formation):
    • A complex enzymatic cascade converting fluid plasma into an insoluble fibrin mesh that seals the vascular breach.
    • Extrinsic Pathway: Triggered by extravascular tissue damage. Direct, rapid pathway taking seconds.
      • Damaged tissue releases Tissue Factor (Factor III / Thromboplastin).
      • Factor III forms a complex with Factor VII, activating Factor VIIa.
      • Factor III + VIIa complex activates Factor X (Stuart-Prower factor).
    • Intrinsic Pathway: Triggered by intravascular factor contact with exposed collagen or altered vessel endothelium. Slower, complex pathway taking minutes.
      • Factor XII (Hageman factor) activates Factor XIa.
      • Factor XIa activates Factor IXa (Christmas factor).
      • Factor IXa combines with Factor VIIIa (Antihemophilic Factor A) in the presence of $\text{Ca}^{2+}$ (Factor IV) to form an enzymatic complex that activates Factor X.
    • Common Pathway: Extrinsic and Intrinsic pathways converge at activated Factor X (Factor Xa).
      • Factor Xa combines with Factor V (Proaccelerin) to form the prothrombinase enzyme complex.
      • Prothrombinase converts Factor II (Prothrombin) into the active enzyme Factor IIa (Thrombin).
      • Thrombin converts soluble Factor I (Fibrinogen) into insoluble Factor Ia (Fibrin) strands.
      • Factor XIII (Fibrin-Stabilizing Factor) cross-links fibrin polymers into a stable meshwork, trapping RBCs and platelets.

• Summary of Essential Clotting Factors

  • Factor I: Fibrinogen (Liver source; Common pathway precursor).
  • Factor II: Prothrombin (Liver source; Common pathway enzyme precursor).
  • Factor III: Tissue Factor / Thromboplastin (Tissue source; Extrinsic pathway initiator).
  • Factor IV: Calcium ions ($\text{Ca}^{2+}$; present and essential in all three pathways).
  • Factor V: Proaccelerin (Liver/platelet source; Intrinsic and Extrinsic convergence).
  • Factor VI: Unassigned (Historical artifact, no longer recognized).
  • Factor VII: Proconvertin (Liver source; Extrinsic pathway component).
  • Factor VIII: Antihemophilic Factor A (Endothelium source; Intrinsic pathway cofactor).
  • Factor IX: Antihemophilic Factor B / Christmas Factor (Liver source; Intrinsic pathway enzyme).
  • Factor X: Stuart-Prower Factor (Liver source; Common pathway convergence factor).
  • Factor XI: Plasma Thromboplastin Antecedent (Liver source; Intrinsic pathway factor).
  • Factor XII: Hageman Factor (Liver source; Intrinsic pathway initiator).
  • Factor XIII: Fibrin-Stabilizing Factor (Liver/platelet source; Fibrin cross-linking enzyme).

• Fibrinolysis and Endogenous Anticoagulants

  • Fibrinolysis: Enzymatic breakdown of a clot during tissue healing.
    • Endothelial cells release Tissue Plasminogen Activator (tPA), converting inactive plasminogen trapped in the clot to active plasmin.
    • Plasmin enzymatically digests fibrin strands.
    • Bradykinin is released, inducing vasodilation to reverse serotonin/prostaglandin-mediated vasoconstriction.
  • Endogenous Plasma Anticoagulants:
    • Protein C: Inactivates clotting factors within the intrinsic pathway.
    • Tissue Factor Pathway Inhibitor (TFPI): Inhibits extrinsic pathway cascades.
    • Antithrombin: Inactivates thrombin and Factor Xa.
    • Heparin: Short-acting anticoagulant released by basophils and mast cells that enhances antithrombin activity.
  • Pharmacological Anticoagulants: Heparin, Aspirin, Warfarin, Eliquis.

• Coagulation Disorders and Vascular Pathologies

  • Hemophilia: X-linked recessive genetic disorders characterized by factor deficiencies (predominantly affecting males; female expression is rare, though males are affected $14\times$ more frequently).
    • Hemophilia A: Inability to synthesize Factor VIII ($80\%$ of hemophilia cases).
    • Hemophilia B: Deficiency in Factor IX ($20\%$ of hemophilia cases).
    • Hemophilia C: Rare autosomal recessive deficiency in Factor XI.
    • Clinical Management: Treated with recombinant factor replacement infusions.
  • Thrombus Subtypes:
    • Mural Thrombus: Clot attached to the wall of a large vessel; decreases blood flow.
    • Occlusive Thrombus: Clot obstructing a small vessel; completely occludes blood flow.
    • Etiology: Triggered by endothelial wall trauma or venous stasis (e.g., prolonged immobility causing Deep Vein Thrombosis / DVT).
  • Thrombophilia: Hypercoagulable state caused by genetic mutations or acquired conditions (lupus, heparin-induced reactions, polycythemia vera, sickle cell disease, pregnancy, obesity).
  • Embolus and Embolism: An embolus is a thrombus or debris detachment traveling through the circulation. An embolism occurs when an embolus lodges in a vessel, occluding distal perfusion (e.g., Myocardial Infarction / MI, Ischemic Stroke, Pulmonary Embolism / PE).
  • Chronic Venous Insufficiency Progression: Normal veins $\rightarrow$ Spider veins $\rightarrow$ Varicose veins $\rightarrow$ Swelling and skin changes $\rightarrow$ Venous ulceration.

Blood Typing and Transfusion Reactions

• Antigens, Antibodies, and Transfusion Principles

  • Discovered in 1900. Erythrocyte membranes bear surface antigens (glycoproteins/glycolipids) that define blood groups.
  • Self-Antigens: Plasma membrane markers recognized as non-foreign by the recipient's immune system.
  • Isoantibodies (Agglutinins): Plasma immunoglobulins ($\text{IgM}$ and $\text{IgG}$) secreted by B-derived plasma cells that bind specifically to non-self erythrocyte antigens.
  • Transfusion Reaction Mechanics: Incompatible blood administration causes recipient antibodies to bind donor RBC antigens, inducing agglutination (clumping). Clumps occlude small microvessels, producing distal tissue ischemia. Macrophages and complement components induce widespread hemolysis, releasing free hemoglobin into plasma, which precipitates in renal tubules causing acute renal failure.

• The ABO Blood Group System

  • Genetically inherited system governed by specific surface oligosaccharide antigens.
  • Type A: Erythrocytes express A antigens; plasma contains Anti-B antibodies.
  • Type B: Erythrocytes express B antigens; plasma contains Anti-A antibodies.
  • Type AB: Erythrocytes express both A and B antigens; plasma lacks both Anti-A and Anti-B antibodies (Universal erythrocyte recipient).
  • Type O: Erythrocytes lack both A and B antigens; plasma contains both Anti-A and Anti-B antibodies (Universal erythrocyte donor).
  • ABO antibodies develop naturally in early infancy following environmental exposure to identical molecular antigens present in food and gut microbiota.

• The Rh Blood Group System

  • Classified by the presence or absence of the Rh D antigen on erythrocyte membranes.
  • Rh Positive ($\text{Rh}^+$): Rh D antigen present ($85\%$ of the population). Includes types $\text{A}^+$, $\text{B}^+$, $\text{AB}^+$, and $\text{O}^+$.
  • Rh Negative ($\text{Rh}^-$): Rh D antigen absent. Includes types $\text{A}^-$, $\text{B}^-$, $\text{AB}^-$, and $\text{O}^-$.
  • Unlike ABO antibodies, Anti-Rh antibodies do not form spontaneously; they develop only after an $\text{Rh}^-$ individual is exposed to $\text{Rh}^+$ blood (e.g., mismatched blood transfusion or fetal-maternal hemorrhage during childbirth).